Pharmacological Blockade of Fatty Acid Synthase (FASN) Reverses Acquired Autoresistance to Trastuzumab (Herceptin™) by Transcriptionally Inhibiting ‘HER2 Super-Expression’ Occurring in High-Dose Trastuzumab-Conditioned SKBR3/Tzb100 Breast Cancer Cells

International Journal of Oncology - Greece
doi 10.3892/ijo.31.4.769
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Trastuzumab (Herceptin)

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2011English

Development of HER2-specific Humanized Antibody Herceptin (Trastuzumab).

Folia Pharmacologica Japonica
Pharmacology
2003English

Pharmacoeconomic Study of Herceptin® (Trastuzumab) for Breast Cancer Patients

Pharmacoeconomics: theory and practice
2014English

SHP-1 Reverses Trastuzumab Resistance and Migration in HER2-positive Breast Cancer Cells Through the Stat3/P-Stat3 Pathway

Biomedical Research
2018English

Novel Approaches to Target HER2-positive Breast Cancer: Trastuzumab Emtansine

Cancer Management and Research
Oncology
2016English

Personalized Drug Combinations to Overcome Trastuzumab Resistance in HER2-positive Breast Cancer

Biochimica et Biophysica Acta - Reviews on Cancer
Cancer ResearchOncologyGenetics
2014English

Effectiveness of Neoadjuvant Trastuzumab and Chemotherapy in HER2-overexpressing Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2013English

Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy